Aetna (NYSE: AET) reported earnings on July 30. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended June 30 (Q2), Aetna missed estimates on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue grew significantly. Non-GAAP earnings per share expanded significantly. GAAP earnings per share grew significantly.

Margins contracted across the board.

Revenue details
 Aetna logged revenue of $11.54 billion. The 12 analysts polled by S&P Capital IQ hoped for revenue of $11.99 billion on the same basis. GAAP reported sales were 31% higher than the prior-year quarter's $8.84 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $1.52. The 17 earnings estimates compiled by S&P Capital IQ predicted $1.40 per share. Non-GAAP EPS of $1.52 for Q2 were 16% higher than the prior-year quarter's $1.31 per share. GAAP EPS of $1.64 for Q2 were 24% higher than the prior-year quarter's $1.32 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 25.9%, 180 basis points worse than the prior-year quarter. Operating margin was 8.1%, 50 basis points worse than the prior-year quarter. Net margin was 4.6%, 60 basis points worse than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
 Next quarter's average estimate for revenue is $12.98 billion. On the bottom line, the average EPS estimate is $1.59.

Next year's average estimate for revenue is $47.52 billion. The average EPS estimate is $5.81.

Investor sentiment
 The stock has a four-star rating (out of five) at Motley Fool CAPS, with 608 members out of 659 rating the stock outperform, and 51 members rating it underperform. Among 227 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 218 give Aetna a green thumbs-up, and nine give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Aetna is outperform, with an average price target of $67.65.

Is Aetna the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.